Cargando…
Ventilator-associated pneumonia: monotherapy is optimal if chosen wisely
Traditionally, ventilator-associated pneumonia (VAP) has been treated either with double drug therapy or with monotherapy. Double drug therapy has been used to increase spectrum, for possible synergy, and to decrease the emergence of resistance. VAP therapy should be directed primarily against Pseud...
| Autor principal: | |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2006
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1550899/ https://www.ncbi.nlm.nih.gov/pubmed/16677419 http://dx.doi.org/10.1186/cc4908 |